- Home
- WBX vs JSPR Comparison
WBX vs JSPR Comparison
Compare WBX & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBX
- JSPR
- Stock Information
- Founded
- WBX 2015
- JSPR 2018
- Country
- WBX Spain
- JSPR United States
- Employees
- WBX N/A
- JSPR N/A
- Industry
- WBX Industrial Specialties
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WBX Consumer Discretionary
- JSPR Health Care
- Exchange
- WBX Nasdaq
- JSPR Nasdaq
- Market Cap
- WBX 102.7M
- JSPR 85.8M
- IPO Year
- WBX N/A
- JSPR N/A
- Fundamental
- Price
- WBX $6.10
- JSPR $3.51
- Analyst Decision
- WBX Buy
- JSPR Buy
- Analyst Count
- WBX 3
- JSPR 12
- Target Price
- WBX $14.33
- JSPR $31.67
- AVG Volume (30 Days)
- WBX 27.1K
- JSPR 1.4M
- Earning Date
- WBX 07-31-2025
- JSPR 08-12-2025
- Dividend Yield
- WBX N/A
- JSPR N/A
- EPS Growth
- WBX N/A
- JSPR N/A
- EPS
- WBX N/A
- JSPR N/A
- Revenue
- WBX $171,352,140.00
- JSPR N/A
- Revenue This Year
- WBX N/A
- JSPR N/A
- Revenue Next Year
- WBX $44.10
- JSPR N/A
- P/E Ratio
- WBX N/A
- JSPR N/A
- Revenue Growth
- WBX 3.75
- JSPR N/A
- 52 Week Low
- WBX $4.60
- JSPR $2.27
- 52 Week High
- WBX $32.80
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- WBX 90.81
- JSPR 37.54
- Support Level
- WBX $0.29
- JSPR $2.71
- Resistance Level
- WBX $6.44
- JSPR $4.00
- Average True Range (ATR)
- WBX 0.19
- JSPR 0.67
- MACD
- WBX 0.63
- JSPR -0.28
- Stochastic Oscillator
- WBX 93.56
- JSPR 29.21
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.